首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site
【24h】

NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site

机译:NMK-BH2,一种新型的微管 - 解聚双(吲哚基) - 酰亚胺 - 腙,通过在Colchicine - 部位结合到微管蛋白,诱导宫颈癌细胞中的凋亡和自噬细胞死亡

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Microtubules, the key components of the eukaryotic cytoskeleton and mitotic spindle, are one of the most sought-after targets for cancer chemotherapy, especially due to their indispensible role in mitosis. Cervical cancer is a prevalent malignancy among women of developing countries including India. In spite of the remarkable therapeutic advancement, the non-specificity of chemotherapeutic drugs adversely affect the patients' survival and well-being, thus, necessitating the quest for novel indole-based anti-microtubule agent against cervical cancer, with high degree of potency and selectivity.
机译:背景:微管,真核细胞骨架和有丝分裂主轴的关键部件,是癌症化疗的最追捧的靶标之一,特别是由于它们在有丝分裂中的不可或缺的作用。 宫颈癌是包括印度在内的发展中国家妇女的普遍性恶性肿瘤。 尽管治疗性促进了显着性,但化学治疗药物的非特异性对患者的生存和福祉产生不利影响,因此需要寻求对宫颈癌的新型吲哚类的抗微管剂,具有高度效力和 选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号